Axa’s Alder Biopharmaceuticals ALDR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-222,600
Closed -$2.62M 1384
2019
Q2
$2.62M Buy
222,600
+139,900
+169% +$1.69M 0.01% 802
2019
Q1
$1.13M Buy
82,700
+18,700
+29% +$242K ﹤0.01% 956
2018
Q4
$656K Buy
+64,000
New +$819K ﹤0.01% 1043
2018
Q3
Sell
-19,700
Closed -$311K 1420
2018
Q2
$311K Sell
19,700
-538,209
-96% -$8.18M ﹤0.01% 1222
2018
Q1
$7.08M Sell
557,909
-529,300
-49% -$7.66M 0.03% 552
2017
Q4
$12.4M Buy
1,087,209
+95,126
+10% +$1.06M 0.05% 396
2017
Q3
$12.2M Buy
992,083
+661,253
+200% +$6.89M 0.05% 385
2017
Q2
$3.79M Sell
330,830
-12,363
-4% -$229K 0.02% 666
2017
Q1
$7.14M Buy
343,193
+76,435
+29% +$1.69M 0.03% 515
2016
Q4
$5.55M Buy
266,758
+5,068
+2% +$132K 0.03% 549
2016
Q3
$8.58M Sell
261,690
-24,930
-9% -$759K 0.04% 444
2016
Q2
$7.16M Buy
286,620
+33,441
+13% +$905K 0.03% 480
2016
Q1
$6.2M Sell
253,179
-4,090
-2% -$94.7K 0.03% 500
2015
Q4
$8.5M Buy
257,269
+12,760
+5% +$431K 0.04% 431
2015
Q3
$8.01M Buy
244,509
+55,074
+29% +$2.34M 0.03% 438
2015
Q2
$10M Buy
+189,435
New +$6.89M 0.04% 419

Other funds holding ALDR